Goldenwell Biotech annual return on equity
2020
2021
2022
2023
2024
Goldenwell Biotech Return on Equity (ROE) Growth & History (GWLL)
Goldenwell Biotech's return on equity was −710.49% for fiscal 2024.
View full Goldenwell Biotech company overviewGoldenwell Biotech annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −710.49% | −628.39 pp |
| 2023 | 2023-12-31 | −82.11% | +309.32 pp |
| 2022 | 2022-12-31 | −391.43% | −348.91 pp |
| 2021 | 2021-12-31 | −42.52% | −39.96 pp |
| 2020 | 2020-12-31 | −2.55% | — |
Goldenwell Biotech quarterly return on equity
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2024 | 2024-09-30 | −200.00% | −171.27 pp |
| Q2 2024 | 2024-06-30 | −174.83% | −157.30 pp |
| Q1 2024 | 2024-03-31 | −45.05% | −26.86 pp |
| Q4 2023 | 2023-12-31 | −21.92% | +397.78 pp |
| Q3 2023 | 2023-09-30 | −28.73% | −26.82 pp |
| Q2 2023 | 2023-06-30 | −17.53% | −7.02 pp |
| Q1 2023 | 2023-03-31 | −18.18% | −6.47 pp |
| Q4 2022 | 2022-12-31 | −419.70% | −410.36 pp |
| Q3 2022 | 2022-09-30 | −1.92% | +3.30 pp |
| Q2 2022 | 2022-06-30 | −10.51% | −3.98 pp |
| Q1 2022 | 2022-03-31 | −11.71% | +3.13 pp |
| Q4 2021 | 2021-12-31 | −9.33% | −8.14 pp |
| Q3 2021 | 2021-09-30 | −5.22% | −4.87 pp |
| Q2 2021 | 2021-06-30 | −6.54% | — |
| Q1 2021 | 2021-03-31 | −14.84% | — |
| Q4 2020 | 2020-12-31 | −1.19% | — |
| Q3 2020 | 2020-09-30 | −0.35% | — |
Goldenwell Biotech return on equity trends
Between the periods ended 2020-12-31 and 2024-12-31, Goldenwell Biotech's return on equity decreased from −2.55% to −710.49%, a change of −707.94 percentage points. The latest reported quarter, Q3 2024, shows −200.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Goldenwell Biotech source filings ↗